IL13 and allergic disease: This complex interconnected biology among these Th2 cytokines could explain why a single blockade could not reduce certain allergic biomarkers, while the dual blockade of both TSLP as the initiator and IL-4/IL-13 as central mediators could provide a more comprehensive control of all aspects and stages of allergic disease progression.